Showing 7881-7890 of 19312 results for "".
What to Know About a State-of-the-Art Approach to GIST Treatment
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/what-to-know-about-a-state-of-the-art-approach-to-gist-treatment/9949/Ronald DeMatteo, MD, of Penn Medicine talks about diagnosis, treatment and research for the rare Gastrointestinal Stromal Tumor (GIST).Therapeutic Substitution Could Help Lower Prescription Drug Costs
https://reachmd.com/programs/the-jama-report/therapeutic-substitution-could-help-lower-prescription-drug-costs/8117/Researchers reviewed prescription drug records and estimated how much money could be saved using therapeutic substitution.New Treatment for Advanced Melanoma Shows Promise
https://reachmd.com/programs/the-jama-report/new-treatment-advanced-melanoma-shows-promise/8066/Researchers from UCLA studied tumor response and overall survival following the administration of a new treatment for patients with advanced melanoma.Care Collaborations for Psoriatic Arthritis in the Dermatology Setting
https://reachmd.com/programs/beyond-skin-deep/care-collaborations-for-psoriatic-arthritis-in-the-dermatology-setting/10151/The various symptoms of PsA can often make diagnosis and care coordination challenging. What should dermatologists be looking for in their patients?Burnout: Is Personal Happiness the Answer?
https://reachmd.com/programs/practical-dermatology/burnout-is-personal-happiness-the-answer/18191/Physician burnout remains a conversation, and the pandemic dramatically changed the landscape for dermatologists—for better and for worse. Omaha, NE-based Joel Schlessinger, MD, who serves as Chief Cosmetic Surgery Editor of Practical Dermatology® speaks with Las Vegas-based dermatologist H.L. GreenReal-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
https://reachmd.com/clinical-practice/ophthalmology/real-world-switching-to-faricimab-from-legacy-anti-vegfs-in-wet-amd/54288/What were the functional, anatomic, and safety results of switching wet AMD patients to faricimab (Vabysmo, Genentech) from a legacy anti-VEGF agent? Maria Berrocal, MD, is joined by Lejla Vajzovic, MD, as they review the results of a real-world study assessing 84 eyes with wet AMD that underwent atPotassium Channel Opener Promising for Seizure Freedom
https://reachmd.com/programs/practical-neurology/potassium-channel-opener-promising-for-seizure-freedom/49196/Looking Back to Look Forward: Key Dermatology Updates in 2024
https://reachmd.com/programs/clinicians-roundtable/looking-back-to-look-forward-key-dermatology-updates-in-2024/32388/Here’s a quick review of the biggest updates in the dermatology field that helped define 2024.Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
https://reachmd.com/programs/neurofrontiers/amyloid-targeted-therapies-a-new-era-in-alzheimers-disease-treatment/29278/Explore the latest amyloid-targeted therapies and how they might lead to a multifaceted treatment approach for Alzheimer's disease.Chikungunya Virus: A Re-emerging Threat in the Clinical Area
https://reachmd.com/programs/vaccination/chikungunya-virus-re-emerging-threat-clinical-arena/26484/What is Chikungunya Virus?